Neonatal Group B Streptococcal Infection in Australia: A Case–control Study
- 16 March 2023
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in The Pediatric Infectious Disease Journal
- Vol. Publish Ah (5), 429-435
- https://doi.org/10.1097/inf.0000000000003881
Abstract
Background: To determine maternal and neonatal risk factors for, and incidence of, neonatal early-onset group B streptococcus (EOGBS) and late-onset (LOGBS) infection in South Australia (SA) and the Northern Territory (NT). Methods: A case–control study with 2:1 matched controls to cases. The study included tertiary hospitals in South Australia and the Northern Territory, Australia. Retrospective data were collected from a 16-year epoch (2000–2015). Results: Of a total of 188 clinically suspected or confirmed cases, 139 were confirmed, of which 56.1% (n = 78) were EOGBS and 43.9% (n = 61) were LOGBS. The incidence of clinically suspected and confirmed cases of EOGBS was 0.26/1000 live births in SA and 0.73/1000 live births in the NT, and the incidence of confirmed cases was 0.19/1000 for SA and 0.36/1000 for the NT. The incidence of clinically suspected or confirmed LOGBS was 0.18/1000 live births in SA and 0.16/1000 for the NT. The majority of infants with GBS presented with sepsis, pneumonia, or meningitis. Developmental delay was the most commonly recorded long-term complication at 1 year old. Risk factors for EOGBS included maternal GBS carriage, previous fetal death, identifying as Aboriginal and/or Torres Strait Islander, and maternal fever in labor/chorioamnionitis. Conclusions: GBS remains a leading cause of neonatal morbidity and mortality. Adding previous fetal death to GBS screening guidelines would improve GBS prevention. The introduction of maternal GBS vaccination programs should be guided by country-specific disease epidemiology.Keywords
This publication has 33 references indexed in Scilit:
- GBS public awareness, advocacy, and prevention—What's working, what's not and why we need a maternal GBS vaccineVaccine, 2013
- Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: Experience in the United States and implications for a potential group B streptococcal vaccineVaccine, 2013
- An overview of global GBS epidemiologyVaccine, 2013
- Early Onset Neonatal Sepsis: The Burden of Group B Streptococcal and E. coli Disease ContinuesPEDIATRICS, 2011
- Delivery of maternal health care in Indigenous primary care services: baseline data for an ongoing quality improvement initiativeBMC Pregnancy and Childbirth, 2011
- Institution of universal screening for Group B streptococcus (GBS) from a risk management protocol results in reduction of early‐onset GBS disease in a tertiary obstetric unitAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2007
- Group B Streptococcus: global incidence and vaccine developmentNature Reviews Microbiology, 2006
- Early onset neonatal meningitis in Australia and New Zealand, 1992-2002Archives of Disease in Childhood: Fetal & Neonatal, 2005
- Surface Proteins ofStreptococcus agalactiaeand Related Proteins in Other Bacterial PathogensClinical Microbiology Reviews, 2005
- Is being Aboriginal or Torres Strait Islander a risk factor for poor neonatal outcome in a tertiary referral unit in north Queensland?Journal of Paediatrics and Child Health, 2002